Skip to main content
OpenTrials

Clinical trial condition

Central Nervous System Bacterial Infections

Explore clinical trials studying Central Nervous System Bacterial Infections. Study availability and eligibility vary by location and protocol.

178 public trials 16 recruiting studies
Refine in advanced search Browse all conditions

Central Nervous System Bacterial Infections trial results

Completed

Assessment of Antibody Persistence at Eighteen Months After the Completion of the Vaccination Course in Study V72P10

NCT01148524

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +13 more
Locations
  • Centro de Salud Lo Barnechea Santiago, Chile
  • Centro para vacunas en desarrollo. Hospital de Niños Roberto del Río Santiago, Chile
  • Escuela de Medicina de la Universidad de Valparaíso Santiago, Chile
  • Hospital Luis Calvo Mackenna Santiago, Chile
View Trial Details
Completed

Immunogenicity, Safety and Lot to Lot Consistency of Novartis Meningococcal B Recombinant Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants

NCT00657709

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations
  • Grässl Hall in Tirol, Austria
  • Häckel Kirchdorf, Austria
  • Prieler Neufeld A.d. Leitha, Austria
  • Maurer Salzburg, Austria
View all 66 locations
View Trial Details
Completed

Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine

NCT01148017

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations
  • Alabama Clinical Therapeutics 806 St. Vincent's Drive, Suite 615 Birmingham, Alabama, United States
  • Premier Health Research 9317 Firestone Blvd. Downey, California, United States
  • Kaiser Permanente Oakland 3505 Broadway, 6th Floor, Room 624 Oakland, California, United States
  • Center for Clinical Trials, LLC 16415 S. Colorado Ave., Suite 308 Paramount, California, United States
View all 19 locations
View Trial Details
Completed

Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered as Booster Dose at 12, 18 or 24 Months of Age in Toddlers (12-24 Months) Primed With a Three-Dose Immunization Series as Infants in Study V72P12

NCT00944034

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +13 more
Locations
  • Avenue Albert 1er 185, 5000 Namur, Belgium
  • Avenue Hippocrate 10, 1200 Brussels, Belgium
  • Laarbeeklaan 101, 1090 Brussels, Belgium
  • Lindendreef 1, 2020 Antwerpen, Belgium
View all 72 locations
View Trial Details
Completed

Evaluation of Persistence of Anti-meningococcal Bactericidal Antibodies Among Adolescents Who Previously Received MenACWY Conjugate Vaccine

NCT00856297

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations
  • 37, 50 Birmingham Pediatric Associates 806 Saint Vincent's Drive, Suite 615 Birmingham, Alabama, United States
  • 6 Kaiser Permanente Fremont 39400 Paseo Padre Parkway Fremont, California, United States
  • 7 Kaiser Permanente Fresno 4785 North First Street, 3rd Floor Fresno, California, United States
  • 8 Kaiser Permanente Hayward 27303 Sleepy Hollow Ave., 1st Floor, MOB Hayward, California, United States
View all 32 locations
View Trial Details

Related conditions